Warner Chilcott Prevails Vs. Teva In Sarafem Patent Suit
A federal district court has upheld the validity of a patent for Irish drug maker Warner Chilcott's pre-menstrual dysphoric disorder treatment Sarafem, rejecting a challenge by Israeli generics maker Teva Pharmaceuticals....To view the full article, register now.
Already a subscriber? Click here to view full article